What You Should Know:
– Converge Bio, a generative AI platform for accelerated drug discovery and development, today announced it has raised $5.5 million in seed funding, led by TLV Partners.
– Converge Bio’s platform uses large language…
Continue Reading
Global clinical-stage biotech company HuidaGene Therapeutics has received FDA clearance to move forward with its application for its investigational drug, a CRISPR/Cas13 RNA-editing therapy to treat neovascular age-related macular degeneration (nAMD) dubbed HG202, developed…
Continue Reading
What You Should Know:
– miRoncol, a medtech startup, has announced the completion of proof-of-concept studies for a groundbreaking multi-cancer early detection blood test.
– The test utilizes microRNA analysis and machine learning, two technologies recognized…
Continue Reading
What You Should Know:
– Sheba Medical Center, a leading Israeli hospital renowned for its medical innovation, and its innovation arm, ARC Innovation, have announced a collaborative research agreement with Mana.bio.
– The partnership aims to…
Continue Reading
A public-private national project in India has introduced what could be the country’s first comprehensive cancer multi-omics database fifteen years after its founding.The Indian Cancer Genome Atlas (ICGA) focuses on studying cancer biology specific…
Continue Reading
What You Should Know:
– Alida Biosciences (AlidaBio), an innovator in epigenomic research tools, proudly announces the successful completion of a $7.5 million Series A funding round. This funding, led by Genoa Ventures with participation…
Continue Reading
What You Should Know:
– Enable Injections, Inc. (“Enable”), a healthcare innovation company developing and manufacturing the enFuse® wearable drug delivery platform and Serina Therapeutics (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company advancing its POZ Platform™ to develop and…
Continue Reading
Diagnostics startup Geneoscopy earned its first-ever FDA approval this week.
The St. Louis-based company received approval for ColoSense, its noninvasive colorectal cancer screening test. The test — which the FDA designated as a breakthrough device…
Continue Reading
